climbed sharply in early Friday trade, riding a wave of investor optimism after the Fevicol maker posted robust quarterly earnings the previous evening.
The stock opened at ₹1,503.60 on the — up over 3.5 per cent from its previous close of ₹1,450.40 — and was trading at ₹1,485.80, up 2.44 per cent or ₹35.40, as of 10.18 am. The counter saw brisk activity with over 30 lakh shares changing hands, translating to a traded value of ₹450.81 crore in the session so far. The stock hit an intraday high of ₹1,515 before paring some gains, with the total market capitalisation standing at approximately ₹1.51 lakh crore.
Analyst reaction to the Q4 FY26 print has been largely positive, though views on the stock’s near-term upside are mixed. Jefferies maintained a Hold rating with a target of ₹1,390, calling the quarter a beat driven by stronger-than-expected margins, with EBIT margins expanding across both business segments. The brokerage flagged West Asia conflict and volatility in VAM (vinyl acetate monomer) prices as key risks to monitor. SBI Securities noted that the stock currently trades at FY27 and FY28 consensus P/E multiples of 54.8x and 48.3x respectively — a valuation that leaves limited room for upside in their view. The Symbol P/E on NSE stands at 59.69.
Pidilite reported a consolidated net sales of ₹3,572 crore for Q4 FY26, up 14.1 per cent year-on-year. Consolidated EBITDA jumped 31.6 per cent to ₹833 crore, with margins expanding around 310 basis points to 23.3 per cent. Profit after tax rose 36.6 per cent to ₹584 crore. The standout metric was an underlying volume growth of 15.3 per cent for the quarter. The Consumer & Bazaar segment, the company’s primary growth engine, delivered 15.9 per cent revenue growth with a UVG of 15.4 per cent. The B2B segment grew 9.3 per cent, though export revenues were dented by the West Asia conflict.
The board has proposed a final dividend of ₹11.5 per share, subject to shareholder approval.